VACCINES FOR HSV-2

Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in...

Full description

Saved in:
Bibliographic Details
Main Authors NANCY A HOSKEN, MARGARET D. MOORE, SCOTT H. ROBBINS, THOMAS W. JR. DUBENSKY
Format Patent
LanguageEnglish
Portuguese
Published 23.07.2018
Subjects
Online AccessGet full text

Cover

Loading…